Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lie Li

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Pediatric Blood & Cancer|April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.
Vaccine|November 22, 2002
Synthetic AIDS vaccine by targeting HIV receptorChang Yi Wang, Ming Shen, Gary Tam, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemiaHiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor MalignanciesHiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Nature|December 16, 2021
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerYelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Blood|March 25, 2018
Preclinical evaluation of <i>NUDT15</i>-guided thiopurine therapy and its effects on toxicity and antileukemic efficacyRina Nishii, Takaya Moriyama, Laura J Janke, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Clinical and Translational Science|March 20, 2021
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristineBarthelemy Diouf, Claudia Wing, John C Panetta, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Pediatric Blood & Cancer|April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.
Vaccine|November 22, 2002
Synthetic AIDS vaccine by targeting HIV receptorChang Yi Wang, Ming Shen, Gary Tam, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemiaHiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor MalignanciesHiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Nature|December 16, 2021
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerYelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Blood|March 25, 2018
Preclinical evaluation of <i>NUDT15</i>-guided thiopurine therapy and its effects on toxicity and antileukemic efficacyRina Nishii, Takaya Moriyama, Laura J Janke, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Clinical and Translational Science|March 20, 2021
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristineBarthelemy Diouf, Claudia Wing, John C Panetta, et al.
Pageof 12